169 related articles for article (PubMed ID: 1689277)
1. Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF.
Maekawa T; Metcalf D; Gearing DP
Int J Cancer; 1990 Feb; 45(2):353-8. PubMed ID: 1689277
[TBL] [Abstract][Full Text] [Related]
2. Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF.
Maekawa T; Metcalf D
Leukemia; 1989 Apr; 3(4):270-6. PubMed ID: 2467145
[TBL] [Abstract][Full Text] [Related]
3. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
[TBL] [Abstract][Full Text] [Related]
4. The induction and inhibition of differentiation in normal and leukaemic cells.
Metcalf D
Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):99-109. PubMed ID: 1690902
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic actions of leukemia inhibitory factor.
Gough NM; Williams RL
Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.
Metcalf D; Hilton DJ; Nicola NA
Leukemia; 1988 Apr; 2(4):216-21. PubMed ID: 2452326
[TBL] [Abstract][Full Text] [Related]
7. In vivo control of differentiation of myeloid leukemic cells by cyclosporine A and recombinant interleukin-1 alpha.
Lotem J; Sachs L
Blood; 1988 Nov; 72(5):1595-601. PubMed ID: 2460157
[TBL] [Abstract][Full Text] [Related]
8. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells.
Metcalf D
Leukemia; 1989 May; 3(5):349-55. PubMed ID: 2469911
[TBL] [Abstract][Full Text] [Related]
9. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
10. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
Lotem J; Sachs L
Blood; 1988 Feb; 71(2):375-82. PubMed ID: 2447982
[TBL] [Abstract][Full Text] [Related]
11. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
12. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human IL-3 and G-CSF act synergistically in stimulating the growth of acute myeloid leukemia cells.
Pébusque MJ; Faÿ C; Lafage M; Sempéré C; Saeland S; Caux C; Mannoni P
Leukemia; 1989 Mar; 3(3):200-5. PubMed ID: 2465464
[TBL] [Abstract][Full Text] [Related]
15. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
Brach MA; Mertelsmann RH; Herrmann F
Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody that inhibits the action of GM-CSF on normal but not leukaemic progenitors.
Ashman LK; Cambareri AC; Eglinton JM
Leuk Res; 1990; 14(7):637-44. PubMed ID: 1697006
[TBL] [Abstract][Full Text] [Related]
18. The effects of leukemia inhibitory factor and interleukin 6 on the growth of acute myeloid leukemia cells.
Takanashi M; Motoji T; Masuda M; Oshimi K; Mizoguchi H
Leuk Res; 1993 Mar; 17(3):217-22. PubMed ID: 8095566
[TBL] [Abstract][Full Text] [Related]
19. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
20. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells.
Lotem J; Sachs L
Blood; 1989 Aug; 74(2):579-85. PubMed ID: 2546628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
